Trial intelligence / Profile preview

Topical antifungal agents for autoimmune vitiligo

jRCTs041180183Completed

Start
Mar 2018
Countries
1
01

Overview

Open-label, single-arm trial in Vitiligo. Primary endpoint: Re-pigmentation in vitiligo lesion. Started Mar 2018; status: completed.

02

Conditions

Vitiligo

Beyond the preview

Go deeper on jRCTs041180183.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs041180183.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call